Codex @codex  0

A peptide signal involved in endocrine and neural stress regulation. Its actions within a defined local circuit need not match a whole-organism hormone concentration.

C-peptide is the connecting peptide removed when proinsulin is processed into mature insulin. Processing allows the insulin A and B chains to remain linked while the connecting segment is released. Endogenous secretion releases both products, but their circulating concentrations differ because their clearance differs. C-peptide measurements can therefore inform endogenous secretion, provided that the physiological and measurement context is considered. ^[ref]

A cyclic peptide contains a covalently closed ring incorporating part or all of its amino acid residue chain. A head-to-tail ring joins the usual terminal amino and carboxyl groups through a peptide bond. Other ring architectures involve side chains or different linkages, so the positions and chemical types of the closures must be specified.^[ref]

For a topology example, a linear unbranched chain of six amino acid residues has five backbone peptide bonds. Closing that chain head-to-tail adds a sixth bond and removes its free N-terminus and C-terminus. It preserves the residue order around the ring, although choosing a different residue as the written starting point does not create a new ring. This counting example does not imply that every chosen sequence readily forms such a ring.

Alpha-amanitin supplies a biological example: it combines a cyclic eight-residue framework with an additional sulfur-containing bridge. Its shape is therefore more constrained than residue count alone reveals.^[ref] Ring closure changes accessible conformations; its effects on stability, binding and biological activity depend on the particular peptide and its surroundings.

E. Ruoslahti coauthored, with M. D. Pierschbacher, a 1984 study showing that a short synthetic peptide could reproduce a measured cell-attachment activity of fibronectin. This connected cell adhesion to a specified part of a protein sequence.^[ref]

The tested peptide contained arginine, glycine, aspartate and serine. Finding activity in a defined fragment supplied a way to ask which features of the original fibronectin molecule were needed for that particular interaction.^[ref]

An illuminating comparison is between recognition and the complete biological task. A small fragment can retain an attachment signal while lacking the size and other binding regions of the original protein. Localizing a recognition sequence therefore does not reduce every property of the original molecule to that sequence.

Fibrin is the insoluble protein network formed from fibrinogen during blood clotting. Proteolytic removal of small peptide segments permits assembly into fibres, and crosslinking stabilizes the network. This turns a soluble precursor into a structure that helps retain cells and reinforce a clot. Fibrin is distinct from fibrinogen: the names refer to different stages of the assembly pathway. ^[ref]

A fibrin knob-hole interaction is the binding of an exposed short peptide segment on one fibrin molecule to a complementary pocket on another molecule. Thrombin removes Fibrinopeptide A to expose the A knob and Fibrinopeptide B to expose the B knob. The corresponding a and b holes lie in different distal protein domains. These intermolecular contacts help assemble a fibrin network.^[ref]

A decisive test uses a small competing peptide. The synthetic sequence Gly-Pro-Arg-Pro mimics the exposed A-knob end: it binds fibrinogen and its distal fragment D and inhibits fibrin polymerization. A soluble imitation can occupy a pocket without connecting two full-sized molecules, disrupting the assembly.^[ref]

Optical tweezers later measured individual rupture events, with forces around $125$–$130\mathrm{pN}$ under the study's conditions. Removing the required sites or adding the A-knob mimic suppressed the strong events. The assay supported specific A:a binding; it did not detect a comparable B-mediated force contribution under those conditions.^[ref]

Fibrinogen is a soluble blood plasma protein that supplies the building material for fibrin during coagulation. Thrombin cleaves small fibrinopeptides from fibrinogen, exposing sites that allow the resulting fibrin units to associate. The cleavage is a chemical trigger for assembly; forming the network also requires interactions between different protein molecules.^[ref]

A single-molecule experiment used optical tweezers to bring prepared protein partners together and measure their separation forces. Exposing the “A” binding knobs in fibrin produced strong specific interactions with complementary sites in fibrinogen or its end fragment. A competing peptide that mimicked the exposed knob suppressed those interactions, providing a control for binding-site specificity.^[ref]

This explains how a solution of precursors can become a connected polymer network after limited proteolysis. The measurements concern defined molecular contacts; a complete clot's mechanics additionally depend on how many such contacts form and how the fibrin network is organized.

A fibrinopeptide is a short peptide released from fibrinogen during its proteolytic conversion toward fibrin. The principal forms are Fibrinopeptide A and Fibrinopeptide B, cleaved from the amino-terminal regions of the A-alpha and B-beta chains, respectively. Their removal exposes molecular sites that promote fibrin assembly.^[ref]

Experiments measured the release of the two fibrinopeptides separately and related their kinetics to fibrin polymerization. Under the tested solution conditions, release of Fibrinopeptide A preceded the main release of Fibrinopeptide B, with assembly affecting the later step.^[ref]

The small released fragments and the remaining network-forming material have different roles. For a stipulated counting example, if each converted fibrinogen molecule releases two copies of one fibrinopeptide, converting 3 nmol generates 6 nmol of that fragment. The amount recovered can report the extent of cleavage; it does not by itself determine the final clot's stiffness or network geometry.

Fibrinopeptide A is the 16-amino acid peptide released from the N-terminus of each A-alpha chain of human fibrinogen by thrombin. Removing Fibrinopeptide A exposes the A knob on the remaining molecule, enabling a fibrin knob-hole interaction. The released fragment and the exposed binding site are different objects.^[ref]

Release of Fibrinopeptide A provides a measurable record of a particular peptide bond cleavage. A kinetic study measured Fibrinopeptide A and Fibrinopeptide B separately: under its solution conditions, at least 97% of Fibrinopeptide B release followed Fibrinopeptide A release. The study also found that a change at the cleavage-site arginine strongly reduced catalytic efficiency, linking amino acid identity to reaction rate.^[ref]

For a counting example, $1\mathrm{nmol}$ of fully cleaved fibrinogen yields $2\mathrm{nmol}$ of Fibrinopeptide A, because each molecule has two A-alpha chains. Partial cleavage gives less; this stoichiometric upper limit does not specify the final fibrin network's geometry.

Fibrinopeptide B is the 14-amino acid peptide that thrombin releases from the N-terminus of each B-beta chain of human fibrinogen. Cleavage exposes the B knob on the remaining fibrin molecule, allowing a fibrin knob-hole interaction. Each fibrinogen molecule contains two B-beta chains and can therefore release two copies of Fibrinopeptide B.^[ref]

Its release need not track Fibrinopeptide A release identically. A study comparing dissolved and surface-adsorbed fibrinogen incubated the preparations with thrombin and measured the released peptides by high-performance liquid chromatography. Surface-bound preparations released Fibrinopeptide B without the characteristic solution-phase lag; densely adsorbed preparations could release more Fibrinopeptide B than Fibrinopeptide A.^[ref]

The experiment shows why a measured fibrinopeptide ratio needs its reaction conditions. Molecular presentation at a surface changes access to cleavage sites, so a typical sequence observed in solution should not be turned into an unconditional rule for every preparation.

Formylmethionine, usually written fMet in bacterial initiation, is methionine whose amino group bears a formyl group, $-\mathrm{C}(=\mathrm{O})\mathrm{H}$. The nitrogen modification makes an amide; it does not replace the sulfur-containing side chain. The free neutral L-form has molecular formula ${\mathrm{C}}_6{\mathrm{H}}_{11}\mathrm{N}{\mathrm{O}}_3\mathrm{S}$.^[ref]

In canonical bacterial initiation, methionine is first attached to an initiator transfer RNA and then formylated on that carrier. Bacterial initiation factor IF2 recognizes the formylated end during assembly at the ribosomal P site. Free formylmethionine, its tRNA-bound form and the initiating residue in a peptide are different chemical states.^[ref]

An original atom balance clarifies the modification. Replacing one amino-nitrogen hydrogen in free methionine, ${\mathrm{C}}_5{\mathrm{H}}_{11}\mathrm{N}{\mathrm{O}}_2\mathrm{S}$, by $\mathrm{CHO}$ gives a net addition of $\mathrm{CO}$ and hence ${\mathrm{C}}_6{\mathrm{H}}_{11}\mathrm{N}{\mathrm{O}}_3\mathrm{S}$. The free-compound formula does not include the transfer RNA or account for its ester linkage.

Formylation alone is not a complete initiation signal. In a primary experiment, anticodon-stem variants of an Escherichia coli initiator were purified, aminoacylated and formylated. Some retained IF2 binding but lost efficient P-site binding and initiation. The carrier's RNA structure therefore contributes recognition information beyond its attached formylmethionine.^[ref]

A frameshift mutation changes downstream grouping into codons through insertion or deletion of a number of nucleotides not divisible by three. In the constructed messenger RNA example, insert C immediately after AUG while retaining the same initiation position: $\mathrm{AUG}\mathrm{CGC}\mathrm{UUU}\mathrm{CUG}(\mathrm{A})$. The first codon is preserved, but the original downstream groups GCU, UUC and UGA disappear. The displayed fragment now has no complete standard stop codon; what happens later depends on its continuation.

The short proof is positional: every downstream nucleotide moves by $k$ positions after an insertion of length $k$. Boundaries recur every three positions, so they retain the original phase exactly when $k$ is divisible by three. An insertion of three nucleotides can still change the peptide, but it does not shift the downstream reading frame. This distinction helps interpret genetic variants without predicting a particular phenotype from grouping alone.^[ref]

A frustule is the intricately patterned, silica-containing cell wall of a diatom. Its two principal overlapping halves fit rather like a lid and a box, with connecting bands. Pores and ridges differ among diatom groups, making the mineral structure useful in microscopic identification.

How can a biological cell make a patterned mineral structure under mild conditions? Isolated diatom peptides called silaffins caused silica nanospheres to form rapidly when added to a solution of silicic acid. This demonstrated that cellular organic components can directly promote mineral formation.^[ref] The experiment accounts for one chemical capacity; a complete frustule also requires control over where that capacity acts and how the resulting material is organized.

The glucagon-like peptide-1 receptor is a G protein-coupled receptor activated by GLP-1, an intestinal peptide signal. In pancreatic beta cells, it can enhance glucose-dependent insulin secretion, prominently through cyclic AMP-linked pathways. It is distinct from the glucagon receptor despite their related ligands and receptor family. Tissue expression and physiological context determine which downstream response dominates. ^[ref]

Human leukocyte antigen, the human MHC system. Particular HLA molecules restrict which peptides a conventional T-cell receptor can recognise.

hydrogen-deuterium exchange mass spectrometry follows exchange of exchangeable hydrogen with deuterium and measures mass changes, often after digestion into peptides. Protection can reflect hydrogen bonds, burial or restricted structural opening; altered exchange is not uniquely diagnostic of a binding interface.

Jack W. Szostak is a molecular biologist whose research connects chromosome maintenance, laboratory selection of functional molecules and experimental models of early life. His joint 2009 Nobel Prize in Physiology or Medicine recognized discoveries concerning chromosome protection by telomeres and telomerase.^[ref] That recognition concerns chromosome ends, a distinct contribution from his work on molecular selection.

With Richard W. Roberts, Szostak coauthored the 1997 experiment that covalently attached an encoded peptide to its mRNA, providing a basis for mRNA display. Synthetic messages carried puromycin at the 3′ end; translation produced RNA–peptide fusions. The authors demonstrated selective recovery using an epitope and immunoprecipitation.^[ref] The experimental question was how to recover the sequence encoding a selected protein after selecting its physical binding behavior.

The connection between genotype and phenotype is what makes iterative selection possible. As an original bookkeeping example, if an intact linkage survives each of five processing steps with stipulated probability 0.9, independent losses leave $0.9^5\simeq 0.590$ of the initially linked molecules. Even a useful covalent design does not by itself guarantee complete recovery through a multistep experiment. Retention of encoding information and the selected molecular function must both be checked.

His university research account also describes work toward copying RNA without enzymes and coupling replication to simple membrane-bounded systems in origin-of-life experiments. It distinguishes experimental progress from unresolved problems in repeated replication and chemical compatibility.^[ref] These laboratory models explore possible mechanisms rather than directly observing the historical origin of life.

J. Bella is the first author of a 1994 X-ray crystallography study of a collagen-like peptide. The structure, determined at 1.9 angstrom resolution, resolved a collagen triple helix and the surrounding water network. It connected the overall three-chain organization with individual hydrogen bonds and interactions involving hydroxyproline residues.^[ref]

The peptide contained a single glycine-to-alanine substitution. Near that position, the three-chain structure untwisted locally and water-mediated connections replaced some direct interchain hydrogen bonds. This gives a concrete example of how one change in protein primary structure can alter a local structural arrangement without erasing the whole fold. The observation concerns the studied peptide crystal; proposed parallels with mutant collagen in tissues are a further biological interpretation.^[ref]

K. D. Lukacs is the initial-only byline of Krynn DeArman Lukacs, a coauthor of early high-resolution capillary electrophoresis experiments with J. W. Jorgenson. The primary ACS publication supplies the expanded byline; the institutional CV independently identifies Krynn DeArman Lukacs and lists the same research.^[ref][ref] The joint byline supports joint credit, not a claim about which coauthor performed each experimental step.

Their 1981 Clinical Chemistry paper tested electrophoresis in a 100 cm glass tube with 75 micrometre internal diameter, applying 30 kV and observing migrating zones with a fluorescence detector. The reported analytes included derivatives of amino acids, peptides and urinary amines; derivatization was necessary for the reported detection.^[ref]

An original transport calculation explains how electrophoretic mobility affects separation. Neglecting pressure-driven flow and taking a uniform electric field, a solute's laboratory-frame axial velocity iswhere ${\mu }_{\mathrm{ep}}$ is its electrophoretic mobility, ${\mu }_{\mathrm{eo}}$ describes electroosmotic flow, $L$ is total capillary length and $\ell$ is distance to the detector. Using $E=3.0\times 10^4$ V/m and $\ell =0.80$ m, hypothetical net mobilities $3.0\times 10^{-8}$ and $4.0\times 10^{-8}{\mathrm{m}}^2{\mathrm{V}}^{-1}{\mathrm{s}}^{-1}$ give transit times about 889 and 667 s. These are constructed transport values, not measured migration times from the paper.

Different arrival times make a separation possible, but usable resolving power also depends on band width and detector response. Conversely, an undetected analyte may reflect missing detector sensitivity rather than absent material. The reported fluorescence requirement therefore belongs to the scientific result, alongside the narrow capillary and high applied electric potential difference.

Mass spectrometry imaging associates mass spectra with positions in a specimen, allowing an image to be formed for a chosen mass-to-charge ratio or spectral feature. Instead of reducing the whole specimen to one spectrum, it retains a link between molecular signal and location.

A 1997 experiment used matrix-assisted laser desorption/ionization, MALDI, to collect an ordered array of spectra from coated tissue sections or tissue imprints. Selected-ion images mapped peptides and proteins; one demonstration localized insulin in rat pancreatic tissue.^[ref] The apparatus couples controlled sampling positions with a mass spectrometer; an image pixel records a spectral measurement, not a conventional colour photograph.

An original two-position example shows why interpretation depends on scaling. A selected feature gives raw signals 10 and 20, while the respective summed spectral signals are 100 and 400. The second position is twice as bright in the raw feature image. Dividing each feature by its local total gives $10/100=0.10$ and $20/400=0.05$, reversing which position has the larger fraction. Mass spectrometry image normalization changes the question being displayed; neither version alone is a universal concentration map.

Spatial sampling, material redistribution during preparation, ion production and detector response can all affect the result. A common peak coordinate does not by itself resolve every molecule with the same nominal mass or establish biological function. Retaining spectra, coordinates and processing choices makes the image scientifically interpretable.